EGFR GENE MUTATION
Clinical trials for EGFR GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR GENE MUTATION trials appear
Sign up with your email to follow new studies for EGFR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Drug-Resistant lung cancer: combo therapy shows promise
Disease control CompletedThis study tested a combination of chemotherapy drugs (platinum and pemetrexed) plus an immunotherapy drug (atezolizumab), with or without another drug (bevacizumab), in 150 people with advanced non-squamous lung cancer that has specific gene changes (EGFR, ALK, or ROS1) and has …
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New pill shows promise for lung cancer patients with brain metastases
Disease control CompletedThis study tested a new drug called AZD3759 against standard targeted therapies (gefitinib or erlotinib) in 492 adults with advanced lung cancer that has a specific gene mutation (EGFR) and has spread to the brain. The goal was to see if AZD3759 could better delay cancer growth. …
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2, PHASE3 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 06:21 UTC